Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Elevance Health Inc banner

Elevance Health Inc
SWB:A58

Watchlist Manager
Elevance Health Inc Logo
Elevance Health Inc
SWB:A58
Watchlist
Price: 359.6 EUR 10.58% Market Closed
Market Cap: €83.4B
Write Note Create Alert Ask AI

Wall St Price Targets

A58 Price Targets Summary
Elevance Health Inc

Wall Street analysts forecast A58 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for A58 is 399.45 EUR with a low forecast of 340.89 EUR and a high forecast of 443.66 EUR.

A58 Lowest Forecast
Wall Street Target
€340.89
-5% Downside
A58 Average Forecast
Wall Street Target
€399.45
11% Upside
A58 Highest Forecast
Wall Street Target
€443.66
23% Upside
Lowest Forecast
Price Target
340.89 EUR
5% Downside
Average Forecast
Price Target
399.45 EUR
11% Upside
Highest Forecast
Price Target
443.66 EUR
23% Upside
Elevance Health Inc Competitors:
Price Targets

Revenue
Forecast

9% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
9% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 3%.

What are analyst estimates?

Net Income
Forecast

6% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
6% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 8 years is 8%.

What are analyst estimates?

Continue A58 Research

Summary
A58 intrinsic value, competitors valuation, and company profile.
DCF Valuation
A58 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
A58 stock valuation using valuation multiples.
Wall St Estimates
A58 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
A58 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Elevance Health Inc listings:
LSE • USD
0HG8
 F • EUR
A58
 NYSE • USD
ELV
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is A58's stock price target?
Price Target
399.45 EUR

According to Wall Street analysts, the average 1-year price target for A58 is 399.45 EUR with a low forecast of 340.89 EUR and a high forecast of 443.66 EUR.

What is the Revenue forecast for Elevance Health Inc?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 3%.

What is the Net Income forecast for Elevance Health Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 8 years is 8%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.